Here, we describe the application of the Iterative Bleaching Extends Multiplicity (IBEX) method utilizing commercially available, automated tissue stainers and optimization considerations for the use of tyramide signal amplification-based reagents.
Method Article
Here, we describe the application of the Iterative Bleaching Extends Multiplicity (IBEX) method utilizing commercially available, automated tissue stainers and optimization considerations for the use of tyramide signal amplification-based reagents.
Iterative Bleaching Extends Multiplicity (IBEX) is a highly sensitive tyramide signal amplification (TSA)-based multi-round fluorescence imaging technique enabling detailed examination of numerous protein biomolecules in a single tissue sample through repeated bleaching, re-staining, and image co-registration. Despite its growing adoption for generating highly multiplexed immunostaining, implementing IBEX in an automated fashion through deployment in core facilities offers numerous benefits, including increased throughput, reproducibility, and overall efficiency of laboratory staff. Here, we demonstrate the successful application of IBEX on two broadly utilized autostainer platforms and discuss important optimization considerations for panel design using TSA-based reactions for formalin-fixed, paraffin-embedded (FFPE) tissue samples. This includes the methodology for testing antibody-antigen retrieval sensitivity, an important consideration for IBEX panel design when determining the sequence of antibody development. Additionally, we showcase downstream imaging approaches utilizing commercially available whole-slide scanners and illustrate quality alignment and analysis using commercially available cell phenotyping software. Through detailed descriptions of these methodologies and accompanying videos, we aim to highlight the versatility and ease of IBEX, offering practical guidance for core pathology facilities to integrate IBEX into their existing automated staining platforms.
Iterative Bleaching Extends Multiplicity (IBEX) is a significant advancement in highly sensitive TSA-based, multi-round fluorescent immunohistochemistry, allowing for detailed visualization and quantification of numerous biomolecules within a single tissue sample. By employing repeated cycles of bleaching and re-staining, IBEX enables the examination of complex cellular environments with unparalleled depth and clarity, making it a powerful tool in the field of immunostaining and multiplexed imaging1,2.
Many academic, governmental, and industry entities host core pathology facilities dedicated to supporting a diverse array of tissue-based research methodologies aimed at generating qualitative and quantitative morphomolecular datasets. These cores are critical resources, providing specialized tissue-based services that allow research labs to outsource complex and labor-intensive molecular pathology processes and consult directly with pathologists in study design, assay development, and data interpretation. To ensure consistency and reduce variability across experiments, these core facilities routinely rely on commercially available autostainers-automated instruments designed to perform standardized staining protocols with high reproducibility and efficiency3.
While autostainers have become the backbone of immunostaining in core facilities, enabling high-throughput and consistent results, they have not yet been adapted to accommodate more recent advancements like IBEX. Furthermore, the need for specialized knowledge in panel design, particularly when using tyramide signal amplification (TSA)-based reagents4, adds an additional layer of complexity, limiting the broader adoption of IBEX in routine research workflows. As a result, researchers who wish to take advantage of IBEX's high-resolution, multiplexed imaging capabilities may often be limited by their core facilities' existing equipment. This gap between innovative imaging techniques and the practical realities of core facility operations highlights a barrier to the broader adoption of IBEX in academic research. This work aims to address this barrier by demonstrating the successful application of IBEX on common autostainer platforms, focusing on the use of TSA-based reagents using formalin-fixed, paraffin-embedded (FFPE) tissues. We first discuss the steps necessary to build an IBEX panel using TSA-based dyes, and the cover application of these panels to two different commercially available autostainers. Together, this offers practical guidance on antibody-antigen retrieval sensitivity testing, discussing key considerations for optimizing panel design, and providing an alternative method for panel alignment using commercial software that may be available and through core pathology laboratories.
1. Building of IBEX panels with TSA-based dyes
NOTE: Always use a fresh preparation of antibodies and dyes and store at 4 °C when not in use.
2. IBEX adaptation with autostainers using TSA reagents and whole slide imaging platforms (Figure 3)
NOTE: For comparison of the two validated autostainers used and discussed in this protocol, see Table 4.
3. Analysis of samples with commercially available software
We provide an example of an IBEX panel using TSA-based reagents on Autostainer 2 (Figure 4). Each marker can be clearly delineated, and there is minimal bleedthrough between markers. The image was collected across two rounds of staining. The sample is lung tissue following infection with Mycobacterium tuberculosis. The two IBEX staining panels were aligned using example commercially available software. Using the IBEX approach with optimized TSA reagents (as is described here), the spatial organization of immune cells, inflammatory markers, and specialized lung cells can be seen and appreciated. Proper optimization allows for markers to easily appear with minimal background.

Figure 1: Antigen retrieval testing with a fluorophore with an emission of 520 nm of two different antigens. RAGE and CD3e were imaged utilizing conserved exposure times. The epitope of this RAGE antibody is highly sensitive and susceptible to repetitive antigen retrieval with rapid drop off of assay sensitivity with subsequent antigen retrievals. Conversely, CD3e assay sensitivity improves with multiple rounds of antigen retrieval. Scale bars = 50 µm. Abbreviation: RAGE = Receptor for Advanced Glycation Endproducts. Please click here to view a larger version of this figure.

Figure 2: Example of the importance of sequence development with respect to the umbrella effect. RAGE is a highly expressed marker in AT1 cells, and in combination with CD31, is effectively blocking SARS-CoV-2 immunoreactivity. However, when SARS-CoV-2 IHC is performed first, the signals can all be visualized. Scale bars = 25 µm. Abbreviations: RAGE = Receptor for Advanced Glycation Endproducts; AT1 = Alveolar Type 1; SARS-CoV-2 = Severe acute respiratory syndrome coronavirus 2; IHC = Immunohistochemistry. Please click here to view a larger version of this figure.

Figure 3: Overview of the process using automated staining equipment for the IBEX protocol. Wet mounting for round 2 or higher of the staining process to prevent tissue from drying out. Abbreviation: IBEX = Iterative Bleaching Extends Multiplicity. Please click here to view a larger version of this figure.

Figure 4: Example of IBEX with TSA-based dyes from autostainer 2 on a lung infected with Mycobacterium tuberculosis. Panel 1 contains all dyes, and panel 2 contains dyes that were amenable bleaching. A merged image of all channels across the full IBEX of the lung image is presented. Scale bars = 200 µm. Abbreviations: IBEX = iterative bleaching extends multiplicity; TSA = Tyramide Signal Amplification. Please click here to view a larger version of this figure.
Table 1: An example protocol for validating effects of cycle number on antibodies for 1, 3, and 6 cycle tests. Please click here to download this Table.
Table 2: An example panel 1 with five antibodies for the IBEX autostainer for panel validation. Please click here to download this Table.
Table 3: An example panel 2 with four antibodies for the IBEX autostainer for panel validation. Please click here to download this Table.
Table 4: Comparison of two autostainers. Table summarizing the pros and cons of the Ventana Autostainer and the Bond Rx. Please click here to download this Table.
Table 5: Software summary for image analysis. Table summarizing some of the analysis approaches and software tools available for the analysis of images post-segmentation. Please click here to download this Table.
Here, we provide considerations for adapting the IBEX protocol into core pathology facilities with the application of automated staining equipment and optimization of TSA-based reagents in the IBEX protocol. We demonstrate how to best optimize for the repeated rounds of antigen retrieval and proper loading in round 2 or higher onto the automated equipment. In addition, we demonstrate an additional method of performing alignment using the Halo software that may be available in core facilities. These approaches have been demonstrated to be useful in determining the differences in lung environments in non-human primate tissue following SARS-CoV-2 infections5.
A key component of this work is highlighting the need for extensive optimization of the IBEX panel design prior to staining of experimental tissues. In particular, with the use of TSA-based reagents, some considerations not seen in the base IBEX methods must be taken into consideration. The first is the impact of multiple rounds of antigen retrieval on antibody sensitivity. With TSA-based reagents, each new antibody development is preceded by antibody denaturation. Some antibodies/antigen pairs will be susceptible to additional rounds of antigen retrieval and diminish assay sensitivity, whereas some will obtain enhanced sensitivity with repetitive denaturation/antigen retrieval. Careful testing of each antibody in the target tissue before designing the panels is important to ensure best staining practices and inform the sequence order of both the antibodies and fluorescent dyes. Buffers, including both citrate-based (pH 6.0) and Tris-EDTA-based (pH 9.0), are tested for all antibodies to determine the optimal antigen retrieval conditions. This involves systematically evaluating each buffer to identify which one maximizes antigen exposure for a given antibody. Additionally, temperature (e.g., 20-37 °C), incubation time (typically 30-60 min), and blocking conditions are optimized to reduce non-specific background staining and ensure specific binding of the primary and secondary antibodies, if necessary. Blocking before the primary and secondary antibodies may include the use of commercially available blocking reagents to account for tissue-specific autofluorescence or non-specific interactions. Other important considerations that must be optimized before finalizing IBEX panels include the umbrella effect, where shielding of the epitopes can occur if the order is not catered to the specific research question being asked6. To avoid fluorescent bleedthrough, it is typical to put higher-expressing antigen targets into far red channels that have the least bleedthrough and weaker markers in the 480-520 nm range, which will have the best signal-to-noise ratio given these fluorescent dyes are the brightest7. However, care should be given to highly autoflourescent tissue samples that may be brightest in this range; we recommend addressing this issue by imaging tissue without any dyes to address potential levels of autoflouresence. Together, these optimization steps, taken with all normal optimization and controls typically done with IBEX, can inform proper panel design for IBEX with TSA reagents.
In this method, we have demonstrated the use of two common autostainers. However, these approaches could be applied to other autostainer methods as well. The key part here is the optimal removal of coverslips and the wet load for additional staining rounds. Additionally, we do not specify any specific microscope setup. Though kits may recommend the use with certain imaging systems for optimal slide scanning, any microscope setup, particularly an epifluorescence microscope with compatible filter cubes and a broad-spectrum LED light source, should work. Some dyes require multispectral detectors or specialized filter cubes, which may not be available in all laboratories and can present challenges when used with standard filter cubes due to their spectral overlap. These dyes are better separated using multispectral imaging systems or highly specific filters. Some fluorophores fall outside the range of conventional far-red filters (typically ~700 nm) and require a specialized filter cube or detector capable of capturing near-infrared signals. Specialized microscopes are built with these filters, but alternatives are available. These will require additional optimization to determine how the dyes perform in a given microscope configuration.
Multispectral unmixing is highly recommended for multiplex fluorescent IHC, particularly when working with tissues prone to autofluorescence, as it effectively separates the true signal from background noise. Autofluorescence, which often overlaps with the emission spectra of commonly used fluorophores (particularly in higher energy wavelength channels), can obscure or interfere with specific signals, reducing accuracy. Spectral unmixing mathematically disentangles overlapping emission spectra, isolating real fluorescent signals while "cleaning up" unwanted autofluorescence. Spectral unmixing is particularly valuable in IBEX workflows, where achieving the cleanest possible signals is critical due to the iterative nature of the staining and imaging process. In IBEX, signals from multiple rounds of staining are imaged, bleached, and stacked on top of one another to create a composite image. Any autofluorescence or bleedthrough that remains unresolved in one round can propagate through the stacked images, complicating downstream analysis and reducing confidence in marker localization. Spectral unmixing effectively isolates true fluorescence signals from background autofluorescence, ensuring cleaner, more accurate signal detection in each individual round. This signal clarity is essential for generating reliable composite images where multiple markers are analyzed together across rounds, enabling confident phenotyping and spatial analysis. The imaging platform used for this protocol has onboard unmixing capabilities, but more unmixing options are needed for compatibility with other fluorescent whole-slide imaging platforms.
In addition, a limitation of this work is the proprietary nature of the autostainers, as their associated reagents and wash buffers are optimized for these systems, but the specific formulations remain undisclosed. Furthermore, we have focused exclusively on one commercially available image analysis software for whole-slide image analysis and acknowledge that the cost of software licenses may present a financial barrier for some laboratories. Additional analysis software8,9 and options in R seem promising; in particular, the Bodenmiller Group10, who has created a package set that seems optimal for cores, in that IMCDataAnalysis11 is intended for reproducible workflow on multiplexed image downstream analysis in R. However, future efforts are needed to develop and characterize accessible and cost-effective alternatives for whole slide IBEX analysis to ensure broader adoption across resource-limited settings. Furthermore, this approach with the use of the autostainers for IBEX can be adapted for more traditional staining in IBEX, including with fluorescent conjugated primary antibodies, or with standard secondary antibodies without the TSA-based dyes if the tissue is of high enough quality and optimal fixation time to allow for good signal.
Overall, we hope that this work will assist with the application of TSA-based multiplex fluorescent IHC using routinely utilized pathology core facility equipment to more widely adapt IBEX into these environments. This type of application truly highlights the versatility of the IBEX protocol and demonstrates its usefulness in even difficult tissue samples or in large batch approaches.
The authors have no conflicts of interest to declare.
Emily Speranza is supported by start-up funds from the Cleveland Clinic Foundation. This work utilized instruments acquired from NIH SIG grants (S10OD026983 & S10OD030269 to N.A.C.).
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Staining reagent Alexa TSA kits | ThermoFisher | Alternative TSA dyes if Opal microscopy filters are not available. These include Alexa Fluor 488 (blue/green channel), Alexa Fluor 555 or 568 (red channel), Alexa Fluor 647 (far-red channel), Alexa Fluor 750 (near-infrared, if equipped with appropriate filters). | |
| Antibody Arg1 | Cell Signaling | 93668 | Used in Figure 4 at 1:100 |
| Material Blades | Leica Biosystems | Or Similar, high or low profile will depend on tissue type | |
| Antibody CD11b | Abcam | ab133357 | Used in Figure 4 at 1:2000 |
| Antibody CD163 | Abcam | ab182422 | Used in Figure 4 at 1:500 |
| Antibody CD31 | Cell Signaling | 77699S | Used in Figure 2 at 1:100 |
| Antibody CD3e | Dako | A045201-2 | Used in Figure 1 at 1:100 |
| Tool Coplin Jar | Fischer Scientific | 01-816-21 | Or Similar |
| Material Coverslips | VWR | v48393-026 | Or Similar |
| Antibody CX3CR1 | Abcam | ab308613 | Used in Figure 4 at 1:450 |
| Stain DAPI | Akoya | FP1490 | |
| Software FIJI | Used to measure signal intensity | ||
| Slide Fisher Superfront Slides | Fisher Scientific | 22-037-246 | Or similar |
| Software HALO | Indica Labs | Example commerically available image analysis software. Used to align and analyze images. | |
| Antibody Iba1 | Cell Signaling | 17191 | Used in Figure 4 at 1:800 |
| Software inForm | Akoya | Used to measure signal intensity | |
| Antibody iNOS | Abcam | ab283655 | Used in Figure 4 at 1:400 |
| Instrument Leica Bond Rx (or RXm) | Leica Biosystems | 21.2201 | Referred to as "Autostainer 1" in text. Ensure all associated reagents are also avaiable including staining boxes and bulk solutions. |
| Reagent LiBH4 | Sigma-Aldrich | 62460-5G-F | Keep in an anhydrous environment |
| Instrument Mantra Snap | Akoya | Multi-spectral flourscent microscope is needed to deteced the dyes. Example microscope that can be used to detect Opal dyes. | |
| Tool Microtome | Leica Biosystems | Or Similar with prefered accessories such as brushes | |
| Staining reagent Opal IHC 480 Kit | Akoya | FP1500001KT | Used in Figure 4 |
| Staining reagent Opal IHC 6-plex Plex Kit | Akoya | NEL821001KT | 520 and 620 do not bleach, used in Figure 1, 2, and 4 |
| Staining reagent Opal IHC 780 Kit | Akoya | FP1501001KT | Used in Figure 4 |
| Tool Oven | Millipore Sigma | Z683329 | Or Similar, can also be done on autostainer |
| Antibody Pancytokeratin | Abcam | ab9377 | Used in Figure 4 at 1:50 |
| Reagent PBS (optional) | Fisher Scientific | AAJ61196AP | |
| Instrument PhenoImager | Akoya | Multispectral whole slide imaging with onboard spectral unmixing included in software | |
| Reagent ProLong Gold Antifade | Fisher Scientific | P36961 | Or similar aqueous mounting media |
| Antibody ProSP-C n-terminal (ProSPC) | Seven Hills Bioreagents | WRAB-9337 | Used in Figure 4 at 1:250 |
| Antibody RAGE | R&D | MAB1179 | Used in Figure 1 and 2 at 1:50 |
| Reagent Reaction buffer | Roche | NC1895692 | For use with Ventana autostainer |
| Antibody SARS-CoV-2-N | Cell Signaling | 68344 | Used in Figure 2 at 1:1000 |
| Slide TOMO Adhesion CC Microscope Slides-WH | Avantik | SKUSL6519-1 | If tissue adherence is of concern |
| Instrument Ventana Discovery Ultra | Roche | Referred to as "Autostainer 2" in text. Ensure all associated reagents are also avaiable including staining boxes and bulk solutions. | |
| Reagent Wash buffer | Leica Biosystems | AR9590 | For use with Leica Bond autostainer |
| Reagent Water | Fisher Scientific | 15-230-147 | DI is best, not millipore |
| Tool Water Bath | Leica Biosystems | 140607020C1 | Or Similar |
Request permission to reuse the text or figures of this JoVE article
Request Permission